February 2019 Volume 7, Issue 2, Pages 500–508.e11
Tanja Kalic, MSc
,
,
Christian Radauer, PhD
,
Thimo Ruethers, MSc
,
Aya C. Taki, PhD
,
Ines Swoboda, PhD
,
Christiane Hilger, PhD
,
,
Markus Ollert, MD, DMSc
,
Christine Hafner, MD
,
Andreas L. Lopata, PhD
,
Martine Morisset, MD, PhD
,
Heimo Breiteneder, PhDCorrespondence information about the author PhD Heimo BreitenederEmail the author PhD Heimo Breiteneder
,
Annette Kuehn, PhD
Open Access
Background
Objective
To investigate the allergenicity of cartilaginous fish and their α-parvalbumins in individuals allergic to bony fish.
Methods
Sensitization to cod, salmon, and ray among patients allergic to cod, salmon, or both (n = 18) was explored by prick-to-prick testing. Clinical reactivity to ray was assessed in 11 patients by food challenges or clinical workup. IgE-binding to β-parvalbumins (cod, carp, salmon, barramundi, tilapia) and α-parvalbumins (ray, shark) was determined by IgE-ELISA. Basophil activation tests and skin prick tests were performed with β-parvalbumins from cod, carp, and salmon and α-parvalbumins from ray and shark.
Results
Tolerance of ray was observed in 10 of 11 patients. Prick-to-prick test reactions to ray were markedly lower than to bony fish (median wheal diameter 2 mm with ray vs 11 mm with cod and salmon). IgE to α-parvalbumins was lower (median, 0.1 kU/L for ray and shark) than to β-parvalbumins (median, ≥1.65 kU/L). Furthermore, α-parvalbumins demonstrated a significantly reduced basophil activation capacity compared with β-parvalbumins (eg, ray vs cod, P < .001; n = 18). Skin prick test further demonstrated lower reactivity to α-parvalbumins compared with β-parvalbumins.
Conclusions
Most patients allergic to bony fish tolerated ray, a cartilaginous fish, because of low allergenicity of its α-parvalbumin. A careful clinical workup and in vitro IgE-testing for cartilaginous fish will improve patient management and may introduce an alternative to bony fish into patients' diet.
No comments:
Post a Comment